SCHEMBL8313895

SCHEMBL8313895

O=C(c1ccc(Nc2nccc(-c3ccc(S(=O)(=O)C4CCOCC4)cc3)n2)cc1)N1CCC(O)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 15/20 0.54
JAK3 P52333 11/20 0.54
SMG1 Q96Q15 2/20 0.53
MTOR P42345 1/20 0.53
JAK1 P23458 7/20 0.51
TYK2 P29597 4/20 0.51
HDAC1 Q13547 2/20 0.51
HDAC3 O15379 1/20 0.51
NCOR1 O75376 1/20 0.51
HDAC2 Q92769 1/20 0.51
HDAC8 Q9BY41 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
IKBKB O14920 3/20 0.48
CHUK O15111 2/20 0.48
PLK4 O00444 2/20 0.46
CIT O14578 2/20 0.46
GAK O14976 2/20 0.46
ROCK2 O75116 2/20 0.46
PRKD3 O94806 2/20 0.46
CSNK2A2 P19784 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14021396 0.91 IKBKB (0.56) JAK2JAK3SMG1MTORJAK1
SCHEMBL8312451 0.91 IKBKB (0.58) JAK2JAK3SMG1MTORJAK1
SCHEMBL13590786 0.91 IKBKB (0.51) JAK2JAK3SMG1MTORJAK1
SCHEMBL8308557 0.88 IKBKB (0.59) JAK2JAK3JAK1TYK2HDAC1
SCHEMBL8312206 0.88 MTOR (0.50) JAK2JAK3SMG1MTORJAK1
SCHEMBL4067768 0.86 CAMK2D (0.59) JAK2JAK3JAK1TYK2HDAC1
SCHEMBL8312080 0.86 IKBKB (0.52) JAK2JAK3SMG1MTORJAK1
SCHEMBL4071263 0.86 SYK (0.47) JAK2JAK3SMG1MTORJAK1
SCHEMBL8313348 0.85 SMG1 (0.48) JAK2JAK3SMG1MTORJAK1
SCHEMBL13590781 0.85 IKBKB (0.49) JAK2JAK3SMG1MTORJAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 US disclosed
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 US disclosed
WO-2004084901-A1 METHODS FOR TREATING OR PREVENTING AN INFLAMMATORY OR METABOLIC CONDITION BY INHIBITING JNK SIGNAL PHARMACEUTICALS, LLC (US) 2004-10-07 WO disclosed